Tiscornia Gustavo, Singer Oded, Verma Inder M
CSH Protoc. 2008 Aug 1;2008:pdb.prot5009. doi: 10.1101/pdb.prot5009.
INTRODUCTIONThis protocol combines the specificity of small interfering RNA (siRNA)-mediated silencing cassettes with the versatility of lentiviral vectors to stably transduce a wide range of cell types. A short hairpin RNA (shRNA) designed against a given target is cloned into a plasmid containing the pol III promoter. The design uses a 5' forward primer upstream of the pol III promoter and a 3' reverse primer that includes the entire shRNA sequence (i.e., sense, loop, and antisense sequences followed by five Ts), followed by 22 bases complementary to the last 22 bp upstream of the +1 transcriptional start site of the pol III promoter. An NheI-compatible restriction site is included at the 5' end of both forward and reverse primers. A single round of PCR is used to amplify this template. The resulting DNA fragment contains an shRNA expression cassette that can be cloned into a simple cloning vector, tested, and then transferred to the lentiviral vector, or cloned into the lentiviral vector directly. This procedure uses a unique restriction site in the 3' long terminal repeat (LTR). During integration, the 5' LTR of the provirus is copied from the 3' LTR, cloning the H1-driven shRNA into the 3' LTR, resulting in duplication of the silencing cassette. This strategy maximizes the silencing power of the lentiviral vector. The combination of the lentiviral and siRNA technologies provides a powerful tool to achieve long-term down-regulation of specific target genes both in vitro and in vivo.
引言
本方案将小干扰RNA(siRNA)介导的沉默盒的特异性与慢病毒载体的多功能性相结合,以稳定转导多种细胞类型。针对给定靶点设计的短发夹RNA(shRNA)被克隆到含有RNA聚合酶III启动子的质粒中。设计时使用位于RNA聚合酶III启动子上游的5'正向引物和包含整个shRNA序列(即正义链、环和反义链序列,后面跟着五个T)的3'反向引物,随后是与RNA聚合酶III启动子转录起始位点+1上游最后22个碱基互补的22个碱基。正向和反向引物的5'端均包含一个与NheI兼容的限制性酶切位点。使用一轮PCR扩增该模板。所得DNA片段包含一个shRNA表达盒,可将其克隆到简单的克隆载体中进行检测,然后转移到慢病毒载体中,或直接克隆到慢病毒载体中。本方法利用了3'长末端重复序列(LTR)中的一个独特限制性酶切位点。在整合过程中,前病毒的5'LTR从3'LTR复制,将H1驱动的shRNA克隆到3'LTR中,导致沉默盒重复。该策略可使慢病毒载体的沉默能力最大化。慢病毒和siRNA技术的结合提供了一个强大的工具,可在体外和体内实现特定靶基因的长期下调。